The mechanism of cell cycle withdrawal during terminal differentiation is poorly understood. We report here that the cyclin-dependent kinase (CDK) inhibitor p21ciPl/wAFl is induced at early times ofboth keratinocyte and myoblast differentiation. p2jCiPl/WAF1 induction is accompanied by a drastic inhibition of total Cdk2, as well as p21CiPl/wAFl-associated CDK kinase activities. p21ciPl/wAFl has been implicated in p53-mediated G, arrest and apoptosis.
p21ciPl/wAFl is induced at early times ofboth keratinocyte and myoblast differentiation. p2jCiPl/WAF1 induction is accompanied by a drastic inhibition of total Cdk2, as well as p21CiPl/wAFl-associated CDK kinase activities. p21ciPl/wAFl has been implicated in p53-mediated G, arrest and apoptosis.
In keratinocyte differentiation, Cipi/WAFi induction is observed even in cells derived from p53-null mice. Similarly, keratinocyte differentiation is associated with induction of Cipi/WAFI promoter activity in both wild-type and p53-negative keratinocytes. Induction of the Cipi /WAF) promoter upon differentiation is abolished by expression of an adenovirus EIA oncoprotein (dl922/947), which is unable to bind p105-Rb, p107, or cyclin A but which still binds the nuclear phosphoprotein p300. Overexpression of p300 can suppress the ElA effect, independent of its direct binding to E1A. Thus, terminal differentiation-induced growth arrest in both keratinocyte and myoblast systems is associated with induction of Cipi/WAFI expression. During keratinocyte differentiation, Cipi /WAFJ induction does not require p53 but depends on the transcriptional modulator p300.
The mechanisms responsible for cell cycle arrest in terminally differentiating cells are poorly understood. Progression through the cell cycle is controlled by activation of a series of cyclin-dependent kinases (CDKs; ref. 1) . In addition to positive regulation by cyclins, CDK activity is regulated by phosphorylation or dephosphorylation at specific residues, as well as by association with a number of inhibitory proteins (2) .
Among these, a 21-kDa protein (p21CiPl/wAFl) has been identified, which binds in quaternary complexes with CDK kinases, their associated cyclins, and the proliferating cell nuclear antigen (PCNA; refs. 3 and 4). Inhibition of CDK activity by p2lciPl/wAFl depends on the relative stoichiometric amounts of this inhibitor in the complex (5) . Besides regulating CDK activity, p21ciPl/wAFl can directly inhibit DNA replication by blocking the ability of PCNA to activate DNA polymerase 5 (6, 7) .
Induction of Cipl/WAFl gene expression has been previously implicated in p53-mediated growth arrest and apoptosis (8, 9) , as well as cellular senescence, quiescence, transient growth-factor stimulation, and pharmacologically induced differentiation of hematopoietic and hepatoma cells (10) (11) (12) (13) . Mechanisms for the modulation of Cipl/WAFl gene expression other than by p53 activation have not been previously described.
The adenovirus ElA oncoprotein provides a useful tool to interfere with key cellular proteins involved in transcriptional
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and DNA synthesis control, cell cycle, and differentiation. The amino terminal region of ElA is required for transformation (14) and is responsible for repression of a number of viral enhancers, as well as enhancers and promoters of tissuespecific genes induced during differentiation (15) . This region of ElA is characterized by the ability to bind and presumably inactivate a large nuclear phosphoprotein, p300 (15, 16) . This protein contains a bromodomain, a hallmark of several transcriptional coactivators, as well as three cysteine/histidine rich regions (16) . The most carboxyl terminal of these regions is involved in the specific binding to ElA. Overexpression of p300 or a p300 mutant lacking the ElA-binding region can counteract the inhibitory effects of ElA on the simian virus 40 enhancer, suggesting that p300 may function as a coactivator molecule at complex transcriptional regulatory sites (16) .
We report here that p2lCiPl/wAF1 expression is induced at early times of keratinocyte and myoblast differentiation in parallel with a strong decrease in total CDK2 and p21-associated CDK activity. Induction of p2lciPl/wAFl expression in differentiation is unlinked from p53 control, while it depends on a p300-dependent mechanism. Thus, a connection has been established between this transcriptional modulator and a differentiation signal linked to growth arrest.
MATERIALS AND METHODS
Cell Culture. Primary keratinocytes from newborn Sencar mice were cultivated in low-calcium (0.05 mM) medium as described (17, 21) . For all experiments, cells were used 1 week after plating. Differentiation was induced by addition of 2 mM calcium chloride.
Primary keratinocytes lacking the p53 gene were obtained from newborn, p53-null mice (18) .
C2C12 mouse myoblasts grown in 20% (vol/vol) fetal calf serum in Dulbecco's modified Eagle's medium (DMEM) were induced to differentiate by changing the medium to DMEM containing 5% (vol/vol) horse serum (19) .
Northern Hybridization Analysis. Total RNA from keratinocytes and C2C12 myoblasts (20) (Fig. 2A) . Total CDK2 kinase activity was drastically reduced as early as 8 h after induction of differentiation (Fig. 2B) . Inhibition of CDK activity was also found in anti-p21 immunoprecipitates by using either histone or GST-pRb as substrates (Fig. 2C) .
Induction of Cipi/WAFI Expression in Myoblast Differentiation. The myoblast to myotube conversion provides another well-characterized differentiation system. We found that induction of Cipl/WAFI mRNA expression also occurs in this system. Cipl/WAFJ mRNA levels were strongly induced 24 h after inducing myoblast differentiation and further increased by 48 and 72 h (Fig. 3A) . Levels of the p2jcipl/wAFl protein were also increased by 48 h of differentiation as detected by either immunoprecipitation with anti-p21 antibodies (Fig. 3B ) or direct immunoblotting (not shown). Amounts of p21-associated cyclin Dl remained constant, while those of p21-associated CDKs seemed to increase (Fig. 3B) . Even in this case, total CDK2 kinase activity was drastically reduced after induction of differentiation (Fig. 3C) .
Thus, induction of p2lcipl/wAF1 expression is observed in both keratinocyte and myoblast differentiations, in parallel with a block of total CDK2 and p21-associated CDK activity.
Induction of Cipi/WAFI Expression in Keratinocyte Differentiation Is Unlinked from p53 Control. Cipl/WAFJ expression was previously reported to be under p53 control (8, 9) . p53 protein expression was found to decrease in primary keratinocytes induced to differentiate by calcium (Fig. 4A) . To determine conclusively whether p53 protein is required for induction of Cipl/WAFl expression, primary keratinocytes were derived from p53-null mice. Basal levels of Cipl/WAFI mRNA were found to be lower in these cells. However, even in p53-null keratinocytes, calcium treatment caused a significant Cipl/WAFI mRNA induction (Fig. 1C) .
To study further the mechanism of Cipl/WAFl induction during keratinocyte differentiation, we transiently transfected mouse primary keratinocytes with a 2.4-kb DNA fragment of the human Cipl/WAFl promoter linked to a luciferase reporter gene (WWP-luc; ref. 8). Induction of this promoter increased progressively up to 24 h (Fig. SA) . A Cipl/WAFJ promoter lacking the fully conserved p53 recognition site at its 5' end (DM-luc; ref. 8) was similarly induced upon differentiation (Fig. 5B) . Induction of Cipl/WAFl promoter activity was also observed after transient transfection of primary keratinocytes from homozygous p53-null mice (Fig. SB) (-) calf intestine alkaline phosphatase (C.I.P.). Immunoprecipitated proteins were separated on an SDS/5% polyacrylamide gel/0.17% bisacrylamide and visualized by autoradiography. Preliminary experiments showed that the broad band in the 300-kDa range (marked with arrows) was specifically immunoprecipitated by the p300-specific antibodies. A similar comigrating band was also found after immunoprecipitation of ElA-transformed Pam212 keratinocyte lysates (24) with anti-ElA antibodies. The weak band in the '200-kDa range is nonspecific, as it was detectable even after immunoprecipitation with antibodies unrelated to p300. (26) as indicated. Transfected keratinocytes were either kept in low-calcium medium (-) or exposed to high calcium (2 mM) (+) for 24 h. (D) Mouse primary keratinocytes in low-calcium medium were transfected with the WWP-luc plasmid (2,g per 60-mm dish) alone or together with decreasing amounts of the ElA 922/947 plasmid (26) plus or minus a cytomegalovirus expression plasmid carrying either a complete p300 cDNA (4 ,ug per 60-mm dish) or a mutated p300 cDNA which lacks the ElA binding region (p300del-30; ref. 16 ). Transfected keratinocytes were either kept in low-calcium medium or exposed to high calcium concentrations for 24 h. Similar results were obtained in four other independent experiments. tion in differentiating keratinocytes is paralleled by increased promoter activity and is independent of p53 control.
Induction of Cipl/WAFi Expression in Keratinocyte Differentiation Is Dependent on the Transcriptional Modulator p300. The product of the adenovirus EJA oncogene interferes with cell growth and differentiation by binding and inactivating a number of cellular growth regulatory proteins (14) . We tested whether ElA could interfere with the induction of Cipl/WAFI expression, as assayed by transient transfection of primary keratinocytes with the WWP-luc gene. Cotransfection of a fully transforming EIA gene or an ElA mutant able to bind to p105-Rb, p107, p130, or p60-cyclin A but not to the transcriptional modulator p300 (14, 24) , drastically decreased the activity of the Cipl/WAFJ promoter in keratinocytes irrespective of their growing or differentiating conditions (our unpublished observation). In contrast, an ElA mutant (ElA 922/947) which does not interact with the pRb family but still binds to p300 (14, 24) did not significantly affect the basal activity of the Cipl/WAFJ promoter but suppressed its induction by calcium in a dose-dependent fashion (Fig. SC) . We tested whether this effect was due to binding of ElA to p300 by transfecting primary keratinocytes with the EIA gene with or without a cDNA for p300 driven by a cytomegalovirus promoter (16) . Transfection of this cDNA alone had little or no effect on Cipl/WAFJ promoter activity in keratinocytes under either growing or differentiating conditions (Fig. SD and  data not shown) . In contrast, the ability of ElA 922/947 to suppress Cipl/WAFl promoter induction was reversed by the p300 cDNA (Fig. SD) . Such an effect was also observed with a mutated p300 cDNA lacking the ElA binding region (p300del-30; ref. 16 ; Fig. SD) . Thus, overexpression of p300 is sufficient to restore induction of the Cipl/WAFl promoter in differentiation.
In parallel with these findings, immunoprecipitation experiments revealed that the electrophoretic mobility of the p300 protein was increased after 6 h of calcium-induced differentiation (Fig. 4B) . No such effect was observed after TGF-,3 treatment. The different migration rate of p300 immunoprecipitated from growing versus differentiating keratinocytes was abrogated by phosphatase treatment, suggesting that differential phosphorylation of p300 is involved (Fig. 4B) . Terminal differentiation in both keratinocyte and myoblast systems is associated with induction of Cipl/WAFJ expression. In the keratinocyte system, induction of Cipl/WAFl expression is unlinked from p53 control. Finally, induction of this gene is dependent on the ElA-associated p300 protein.
Induction of Cipl/WAFl mRNA expression in terminally differentiating cells is accompanied by increases in p2lcipl/wAFl protein levels in parallel with a decrease of total CDK2 and p21-associated CDK kinase activities. p2lciPl/wAFLcontaining complexes exist in both an active and an inactive form, depending on their stoichiometry (5) . Active complexes appear to contain a single molecule of this inhibitor, whereas inactive ones have multiple subunits (5). These observations, together with the fact that upregulation of the p2lciPl/wAFl protein was observed in both keratinocyte and myoblast differentiation systems, point to this inhibitor as a possible central player in cell-cycle control during differentiation. Future work will have to establish which additional regulatory mechanisms, such as CDK and cyclin modulation, contribute to CDK control during differentiation and whether they may function in a more cell-type-specific manner. However, besides being involved in CDK control, p2lciPl/wAFI could also inhibit DNA polymerase directly (6) .
The onset of myoblast differentiation is associated with an increase of p53 expression (27) , providing a possible mechanism for the observed Cipl/WAFI induction. In keratinocytes, p53 gene expression is decreased in response to calcium. More significant, Cipl/WAFI gene expression is induced by calcium even in the absence of p53. Absolute levels of Cipl/WAFJ expression are lower in the p53-null keratinocytes than in the wild-type control. It will be interesting to determine the modality by which p53-null keratinocytes undergo growth arrest during differentiation, as cell-cycle control of these cells may be significantly abnormal (28) .
Very little is known about control of the Cipl/WAFl gene, besides its being modulated by the p53 protein. Evidence for an as yet uncharacterized p53-independent pathway for upregulation of this gene in human cells has been recently presented (29) . Indirect evidence has implicated the E1A-associated p300 protein in cell-cycle control and differentiation (refs. 15 and 16 and references therein). The effect on the Cipl/WAFl promoter provides the first direct evidence that p300 is involved in transmission of a differentiation signal linked to growth arrest. Suppression of the calcium responsiveness of the Cipl/WAFI promoter by ElA was counteracted to a similar extent by a wild-type p300 and a mutated form lacking the ElA-binding region. This indicates that the positive effect of p300 is not due to a functional sequestration of the ElA protein or simple competition for ElA binding to other p300-related proteins (30) . In the absence of ElA, exogenous p300 was unable to stimulate Cipl/WAFl promoter activity to any significant extent in keratinocytes under either growing or differentiating conditions. Taken together, these observations suggest that the p300 protein is by itself not limiting but is required for other differentiation-related factors to function. An important role of p300 in keratinocyte differentiation is also suggested by the fact that this factor is also required for induction of the involucrin promoter, a well-characterized keratinocyte differentiation marker (ref. 31 and our unpublished observations).
Induction of keratinocyte differentiation is associated with specific protein phosphorylation events (ref. 32 and references therein). ElA has been shown to interfere with phosphorylation of the p300 protein (33) , and the p300 phosphorylation state appears to be altered during calcium-induced keratinocyte differentiation. Future studies will have to address the complex interplay between protein phosphorylation, transcriptional control, and cell-cycle arrest in terminally differentiating cells.
Note Added in Proof. While this manuscript was under review, two similar reports of Cipl/WAFI induction in myoblast differentiation have appeared (34, 35) .
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